MineshRajpalMD

Research History

• Research ScholarVentricular vascular study To characterize systolic interactions between the heart and vasculature in hypertensive and healthy population subgroups and to relate these interactions to optimal and adverse adaptations in the heart, arteries, brain and kidneys.
• Fellowship researchDiagnostic Performance of Blood Pressure Measurement Modality in Living Kidney Donors
• Quality Improvement/ FellowIncreasing appropriate anticoagulation use and documentation in inpatient hemodialysis at Cleveland Clinic
• Resident researchKaleida Quality Improvement Committee QI project on AMI and heart failure.
• Resident researchPreventing readmissions in hemodialysis population at Erie county medical center by implementing a health advocate program vs. enhanced discharge and patient education program.
• Resident researchDetermining health literacy in patients on chronic hemodialysis at Erie county medical center
• Research ScholarEffects of nebivolol and valsartan alone and in combination on 24-hour ambulatory cardiac work and central systolic pressure variability.
• Research ScholarA Multicenter, Randomized, Double-blind, Placebo-Controlled, 8-Week Study to Evaluate the Safety and Efficacy of Nebivolol and Valsartan Given as a Fixed-Dose Combination in Patients with Stage 1 or 2 Essential Hypertension.
• Research ScholarA randomized, double-blind, active-controlled, multicenter, 52-week study to evaluate the safety and efficacy of an LCZ696 regimen on arterial stiffness through assessment of central blood pressure in elderly patients with essential hypertension.
• Research ScholarA multicenter, randomized, double-blind, parallel group, double-dummy, placebo-controlled study to evaluate the 6 months efficacy and safety of aliskiren therapy on top of standard therapy, on morbidity and mortality when initiated early after hospitalization for acute decompensated heart failure.
• Research AssociateAn 8 week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Antihypertensive Efficacy and Safety of Aliskiren Administered in Combination with Valsartan versus Valsartan alone in Hypertensive Patients with Type 2 Diabetes Mellitus.
• Research AssociateA multi-center, randomized, double-blind, placebo and active controlled, parallel group study to evaluate the dose response of AHU377 in combination with valsartan 320mg after 8 week treatment in patients with mild-to-moderate systolic hypertension.